NCT06127940 2023-11-13
K-SAB
Karolinska University Hospital
Phase 1 Unknown
Clinical Trials
5 trialsNCT05407155 2022-06-07
BETTER
Fudan University
Phase NA Unknown
NCT04082182 2021-03-30
MIDRIX4-LUNG
University Hospital, Ghent
Phase 1 Unknown
NCT03656094 2019-12-09
Chemotherapy With Pembrolizumab Continuation After Progression to PD-1/L1 Inhibitors
Samsung Medical Center
Phase 2 Unknown
NCT02041468 2017-08-30
Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients
Jewish General Hospital
Unknown